Evercore ISI Issues Positive Forecast for GE HealthCare Technologies (NASDAQ:GEHC) Stock Price

GE HealthCare Technologies (NASDAQ:GEHC) had its price objective hoisted by Evercore ISI from $88.00 to $92.00 in a report released on Thursday,Benzinga reports. The firm currently has an outperform rating on the stock.

Several other equities analysts have also issued reports on GEHC. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a report on Thursday, September 18th. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Citigroup lowered shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their target price for the company from $93.00 to $83.00 in a report on Tuesday, October 7th. Finally, Barclays began coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price on the stock. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $75.00 on Thursday. The company has a market capitalization of $34.24 billion, a price-to-earnings ratio of 15.50, a PEG ratio of 2.95 and a beta of 1.13. The company has a quick ratio of 0.93, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $94.80. The stock has a fifty day simple moving average of $75.10 and a 200 day simple moving average of $72.91.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. The business had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. GE HealthCare Technologies’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Sell-side analysts expect that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Teacher Retirement System of Texas raised its holdings in shares of GE HealthCare Technologies by 18.9% in the 3rd quarter. Teacher Retirement System of Texas now owns 332,473 shares of the company’s stock worth $24,969,000 after acquiring an additional 52,956 shares during the last quarter. Grandfield & Dodd LLC raised its holdings in shares of GE HealthCare Technologies by 0.5% in the 3rd quarter. Grandfield & Dodd LLC now owns 334,291 shares of the company’s stock worth $25,105,000 after acquiring an additional 1,816 shares during the last quarter. iA Global Asset Management Inc. raised its holdings in shares of GE HealthCare Technologies by 4.2% in the 3rd quarter. iA Global Asset Management Inc. now owns 52,861 shares of the company’s stock worth $3,970,000 after acquiring an additional 2,143 shares during the last quarter. Strs Ohio raised its holdings in shares of GE HealthCare Technologies by 5.7% in the 3rd quarter. Strs Ohio now owns 407,945 shares of the company’s stock worth $30,637,000 after acquiring an additional 22,005 shares during the last quarter. Finally, Leelyn Smith LLC raised its holdings in shares of GE HealthCare Technologies by 6.7% in the 3rd quarter. Leelyn Smith LLC now owns 51,466 shares of the company’s stock worth $3,865,000 after acquiring an additional 3,252 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.